S. Agal, R. Baijal, S. Pramanik, N. Patel, P. Gupte et al., Monitoring and management of antituberculosis drug induced hepatotoxicity, Journal of Gastroenterology and Hepatology, vol.20, pp.1745-1752, 2005.

K. Andries, P. Verhasselt, J. Guillemont, H. W. Gö-hlmann, J. M. Neefs et al., A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis, Science, vol.307, pp.223-227, 2005.

J. A. Armstrong and P. D. Hart, Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli reversal of the usual nonfusion pattern and observations on bacterial survival, The Journal of Experimental Medicine, vol.142, pp.1-16, 1975.

L. B. Barreiro, L. Tailleux, A. A. Pai, B. Gicquel, J. C. Marioni et al., Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection, PNAS, vol.109, pp.1204-1209, 2012.

W. Bi, L. Zhu, C. Wang, Y. Liang, J. Liu et al., Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation, Brain Research, vol.1395, pp.12-20, 2011.

G. Bindea, B. Mlecnik, H. Hackl, P. Charoentong, M. Tosolini et al., ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks, Bioinformatics, vol.25, pp.1091-1093, 2009.

I. A. Biraro, M. Egesa, S. Kimuda, S. G. Smith, F. Toulza et al., Effect of isoniazid preventive therapy on immune responses to Mycobacterium tuberculosis: an open label randomised, controlled, exploratory study, BMC Infectious Diseases, vol.15, p.438, 2015.

R. Blecher-gonen, Z. Barnett-itzhaki, D. Jaitin, D. Amann-zalcenstein, D. Lara-astiaso et al., Highthroughput chromatin immunoprecipitation for genome-wide mapping of in vivo protein-DNA interactions and epigenomic states, Nature Protocols, vol.8, pp.539-554, 2013.

C. J. Cambier, S. Falkow, and L. Ramakrishnan, Host evasion and exploitation schemes of Mycobacterium tuberculosis, Cell, vol.159, pp.1497-1509, 2014.

H. S. Cox, M. Morrow, and P. W. Deutschmann, Long term efficacy of DOTS regimens for tuberculosis: systematic review, BMJ, vol.336, pp.484-487, 2008.

C. De-duve, T. De-barsy, B. Poole, A. Trouet, P. Tulkens et al., Commentary lysosomotropic agents. Biochemical Pharmacology, vol.23, pp.2495-2531, 1974.

M. A. De-matteis, C. Wilson, and G. D'angelo, Phosphatidylinositol-4-phosphate: the golgi and beyond, BioEssays, vol.35, pp.612-622, 2013.

A. H. Diacon, P. R. Donald, A. Pym, M. Grobusch, R. F. Patientia et al., Randomized pilot trial of eight weeks of bedaquiline (TMC207) Treatment for Multidrug-Resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance, Antimicrobial Agents and Chemotherapy, vol.56, pp.3271-3276, 2012.

A. Dobin, C. A. Davis, F. Schlesinger, J. Drenkow, C. Zaleski et al., STAR: ultrafast universal RNA-seq aligner, Bioinformatics, vol.29, pp.15-21, 2013.

R. Edgar, M. Domrachev, and A. E. Lash, Gene expression omnibus: ncbi gene expression and hybridization array data repository, Nucleic Acids Research, vol.30, pp.207-210, 2002.

M. Fiorillo, R. Lamb, H. B. Tanowitz, A. R. Cappello, U. E. Martinez-outschoorn et al., Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like Cancer cells (CSCs), Aging, vol.8, pp.1593-1607, 2016.

N. Germic, Z. Frangez, S. Yousefi, and H. U. Simon, Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation, Cell Death & Differentiation, vol.26, pp.715-727, 2019.

D. J. Greenwood, D. Santos, M. S. Huang, S. Russell, M. Collinson et al., Subcellular antibiotic visualization reveals a dynamic drug reservoir in infected macrophages, Science, vol.364, pp.1279-1282, 2019.

M. G. Gutierrez, S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo et al., Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages, Cell, vol.119, pp.753-766, 2004.

A. C. Haagsma, R. Abdillahi-ibrahim, M. J. Wagner, K. Krab, K. Vergauwen et al., Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue, Antimicrobial Agents and Chemotherapy, vol.53, pp.1290-1292, 2009.

K. Hards, D. Mcmillan, L. A. Schurig-briccio, R. B. Gennis, H. Lill et al., Ionophoric effects of the antitubercular drug bedaquiline, PNAS, vol.115, pp.7326-7331, 2018.

M. Ibrahim, K. Andries, N. Lounis, A. Chauffour, C. Truffot-pernot et al., Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis, Antimicrobial Agents and Chemotherapy, vol.51, pp.1011-1015, 2007.

J. Therapeutics, Sirturo (bedaquiline) US food and drug administration, 2012.

F. Kazmi, T. Hensley, C. Pope, R. S. Funk, G. J. Loewen et al., Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes, 2013.

, Drug Metabolism and Disposition, vol.41, pp.897-905

J. J. Kim, H. M. Lee, D. M. Shin, W. Kim, J. M. Yuk et al., Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action, Cell Host & Microbe, vol.11, pp.457-468, 2012.

A. Koul, N. Dendouga, K. Vergauwen, B. Molenberghs, L. Vranckx et al., Diarylquinolines target subunit c of mycobacterial ATP synthase, Nature Chemical Biology, vol.3, pp.323-324, 2007.

D. W. Lamming and L. Bar-peled, Lysosome: the metabolic signaling hub, Traffic, vol.20, pp.27-38, 2019.

R. E. Lawrence and R. Zoncu, The lysosome as a cellular centre for signalling, metabolism and quality control, Nature Cell Biology, vol.21, pp.133-142, 2019.

R. Levin, G. R. Hammond, T. Balla, D. Camilli, P. Fairn et al., Multiphasic dynamics of phosphatidylinositol 4-phosphate during phagocytosis, Molecular Biology of the Cell, vol.28, pp.128-140, 2017.

W. J. Liu, L. Ye, W. F. Huang, L. J. Guo, Z. G. Xu et al., p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation, Cellular & Molecular Biology Letters, vol.21, p.29, 2016.

M. I. Love, W. Huber, and S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biology, vol.15, p.550, 2014.

A. Machelart, O. R. Song, E. Hoffmann, and P. Brodin, Host-directed therapies offer novel opportunities for the fight against tuberculosis, Drug Discovery Today, vol.22, pp.1250-1257, 2017.

A. C. Macintyre and D. J. Cutler, Role of lysosomes in hepatic accumulation of chloroquine, Journal of Pharmaceutical Sciences, vol.77, pp.196-199, 1988.

C. Manca, M. Koo, B. Peixoto, D. Fallows, G. Kaplan et al., Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection, PLOS ONE, vol.8, p.74082, 2013.

D. L. Medina, D. Paola, S. Peluso, I. Armani, A. et al., Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB, Nature Cell Biology, vol.17, pp.288-299, 2015.

Q. Meilang, Y. Zhang, J. Zhang, Y. Zhao, C. Tian et al., Polymorphisms in the SLC11A1 gene and tuberculosis risk: a meta-analysis update, The International Journal of Tuberculosis and Lung Disease, vol.16, pp.437-446, 2012.

M. Palmieri, S. Impey, H. Kang, A. Di-ronza, C. Pelz et al., Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways, Human Molecular Genetics, vol.20, pp.3852-3866, 2011.

J. Palomino, A. Martin, M. Camacho, H. Guerra, J. Swings et al., Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.46, pp.2720-2722, 2002.

M. W. Pfaffl, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Research, vol.29, pp.45-45, 2001.

M. Plescher, A. A. Teleman, and C. Demetriades, TSC2 mediates hyperosmotic stress-induced inactivation of mTORC1, Scientific Reports, vol.5, p.13828, 2015.

A. Puyskens, A. Stinn, M. Van-der-vaart, A. Kreuchwig, J. Protze et al., Aryl hydrocarbon receptor modulation by tuberculosis drugs impairs host defense and treatment outcomes, Cell Host & Microbe, vol.27, pp.238-248, 2020.

M. J. Reasor, Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs, Federation Proceedings, vol.43, pp.2578-2581, 1984.

A. Remmerie and C. L. Scott, Macrophages and lipid metabolism, Cellular Immunology, vol.330, pp.27-42, 2018.

A. Roczniak-ferguson, C. S. Petit, F. Froehlich, S. Qian, J. Ky et al., The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis, Science Signaling, vol.5, p.42, 2012.

L. A. Sena and N. S. Chandel, Physiological roles of mitochondrial reactive oxygen species, Molecular Cell, vol.48, pp.158-167, 2012.

C. Settembre, D. Malta, C. Polito, V. A. , G. Arencibia et al., TFEB links autophagy to lysosomal biogenesis, Science, vol.332, pp.1429-1433, 2011.

C. Settembre, R. Zoncu, D. L. Medina, F. Vetrini, S. Erdin et al., A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB, The EMBO Journal, vol.31, pp.1095-1108, 2012.

J. A. Shayman and A. A. , Drug induced phospholipidosis: an acquired lysosomal storage disorder, Biochimica Et Biophysica Acta (BBA) -Molecular and Cell Biology of Lipids, vol.1831, pp.602-611, 2013.

D. M. Shin, B. Y. Jeon, H. M. Lee, H. S. Jin, J. M. Yuk et al., Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redoxdependent signaling, PLOS Pathogens, vol.6, p.1001230, 2010.

R. Simeone, A. Bobard, J. Lippmann, W. Bitter, L. Majlessi et al., Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death, PLOS Pathogens, vol.8, p.1002507, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01899479

A. Singhal, L. Jie, P. Kumar, G. S. Hong, M. K. Leow et al., Metformin as adjunct antituberculosis therapy, Science Translational Medicine, vol.6, pp.263-159, 2014.

S. Sturgill-koszycki, P. Schlesinger, P. Chakraborty, P. Haddix, H. Collins et al., Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase, Science, vol.263, pp.678-681, 1994.

L. Tailleux, O. Neyrolles, S. Honoré--bouakline, E. Perret, F. Sanchez et al., Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells, The Journal of Immunology, vol.170, pp.1939-1948, 2003.

L. Tailleux, S. J. Waddell, M. Pelizzola, A. Mortellaro, M. Withers et al., Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages, PLOS ONE, vol.3, p.1403, 2008.

. Tmc207-c208-study, . Group, A. H. Diacon, A. Pym, M. P. Grobusch et al., Multidrug-resistant tuberculosis and culture conversion with bedaquiline, New England Journal of Medicine, vol.371, pp.723-732, 2014.

S. Tousif, D. K. Singh, S. Ahmad, P. Moodley, M. Bhattacharyya et al., Isoniazid induces apoptosis of activated CD4+ T cells: implications for post-therapy tuberculosis reactivation and reinfection, The Journal of Biological Chemistry, vol.289, pp.30190-30195, 2014.

A. Troegeler, C. Lastrucci, C. Duval, A. Tanne, C. Cougoule et al., An efficient siRNA-mediated gene silencing in primary human monocytes, dendritic cells and macrophages, Immunology and Cell Biology, vol.92, pp.699-708, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02348566

N. Tsankov and I. Grozdev, Rifampicin -A mild immunosuppressive agent for psoriasis, Journal of Dermatological Treatment, vol.22, pp.62-64, 2011.

C. Ubeda and E. G. Pamer, Antibiotics, microbiota, and immune defense, Trends in Immunology, vol.33, pp.459-466, 2012.

N. Van-der-wel, D. Hava, D. Houben, D. Fluitsma, M. Van-zon et al., M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells, Cell, vol.129, pp.1287-1298, 2007.

X. Wang, P. M. Grace, M. N. Pham, K. Cheng, K. A. Strand et al., Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain, The FASEB Journal, vol.27, pp.2713-2722, 2013.

A. Wang, H. H. Luan, and R. Medzhitov, An evolutionary perspective on immunometabolism, Science, vol.363, p.3932, 2019.

G. Weiss and U. E. Schaible, Macrophage defense mechanisms against intracellular bacteria, Immunological Reviews, vol.264, pp.182-203, 2015.

T. A. Wynn, A. Chawla, and J. W. Pollard, Macrophage biology in development, homeostasis and disease, Nature, vol.496, pp.445-455, 2013.

A. Yamamoto, S. Adachi, K. Ishikawa, T. Yokomura, and T. Kitani, Studies on drug-induced lipidosis 3. lipid composition of the liver and some other tissues in clinical cases of "Niemann-Pick-like syndrome, The Journal of Biochemistry, vol.70, pp.775-784, 1971.

A. Yamamoto, S. Adachi, T. Kitani, Y. Shinji, and K. Seki, Drug-induced lipidosis in human cases and in animal experiments. Accumulation of an acidic glycerophospholipid, Journal of Biochemistry, vol.69, pp.613-615, 1971.

W. W. Yew, K. C. Chang, D. P. Chan, and Y. Zhang, Metformin as a host-directed therapeutic in tuberculosis: is there a promise?, Tuberculosis, vol.115, pp.76-80, 2019.

H. Yoshikawa, Effects of drugs on cholesterol esterification in normal and Niemann-Pick type C fibroblasts: ay-9944, other cationic amphiphilic drugs and DMSO, Brain and Development, vol.13, pp.115-120, 1991.

Y. Zhang and D. Mitchison, The curious characteristics of pyrazinamide: a review, The International Journal of Tuberculosis and Lung Disease, vol.7, pp.6-21, 2003.